Sovaldi Deal: Gilead Armored From GMP Issues Of Indian Firms
This article was originally published in PharmAsia News
Executive Summary
Gilead says it has reserved rights to audit the facilities of its several Indian partners as part of the Sovaldi licensing agreement to ensure GMP compliance. Plus, other clauses mandate partners to be consistent with national, regional or local standards as may be required.